MS
Michael Skynner
Chief Scientific Officer

Michael Skynner insider trades: Bicycle Therapeutics (BCYC) stock sales

Chief Scientific Officer, Bicycle Therapeutics Last trade Oct 5, 2026 21 Form 4 filings
$72K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
16
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

16 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 5, 2026BCYC↓ Sell$9K
Jul 6, 2026BCYC↓ Sell$10K
Apr 6, 2026BCYC↓ Sell$12K
Jan 5, 2026BCYC↓ Sell$42K
Oct 3, 2025BCYC↓ Sell$15K
Jul 3, 2025BCYC↓ Sell$13K
Apr 3, 2025BCYC↓ Sell$14K
Jan 3, 2025BCYC↓ Sell$60K
Oct 3, 2024BCYC↓ Sell$22K
Jul 3, 2024BCYC↓ Sell$19K
Apr 3, 2024BCYC↓ Sell$23K
Jan 3, 2024BCYC↓ Sell$46K
Oct 3, 2023BCYC↓ Sell$9K
Jul 3, 2023BCYC↓ Sell$11K
Apr 3, 2023BCYC↓ Sell$9K
Jan 3, 2023BCYC↓ Sell$52K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BCYC insiders

Open-market trades in the last 12 months

About Michael Skynner's insider trades

Michael Skynner is Chief Scientific Officer at Bicycle Therapeutics (BCYC). Since Jan 3, 2023, Michael has reported no open-market purchases and 16 sales worth $367K on SEC Form 4. In the last 12 months: 4 sales ($72K).

Their filings also include grants and awards (9 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BCYC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.